ArticleOncogene2025
LRRK2 reduces the sensitivity to TKI and PD-1 blockade in ccRCC via activating LPCAT1.
Yulong Hong et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
5 papers cite it
this papercites it
ArticleOncogene2025
Yulong Hong et al.PubMed ↗Publisher ↗
No numbers read from the abstract.